×
About 1,805 results

ALLMedicine™ Liver Diseases Center

Research & Reviews  801 results

Trends in the Economic Burden of Chronic Liver Diseases and Cirrhosis in the United Sta...
https://doi.org/10.14309/ajg.0000000000001292
The American Journal of Gastroenterology; Ma C, Qian AS et. al.

May 17th, 2021 - The management of chronic liver diseases (CLDs) and cirrhosis is associated with substantial healthcare costs. We aimed to estimate trends in national healthcare spending for patients with CLDs or cirrhosis between 1996 and 2016 in the United Stat...

Subjective Global Nutritional Assessment as a nutritional tool in childhood chronic liv...
https://doi.org/10.1017/S0007114521001604
The British Journal of Nutrition; Pawaria A, Khanna R et. al.

May 14th, 2021 - Objective of the study was to assess subjective global nutritional assessment (SGNA) in children with chronic liver diseases (CLD). Children aged 3 months to 18 years with CLD were prospectively enrolled (January 2016 to October 2018). SGNA was pe...

Diagnosis, evaluation, and management of ascites and hepatorenal syndrome.
https://doi.org/10.1002/hep.31884
Hepatology (Baltimore, Md.); Biggins SW, Angeli P et. al.

May 4th, 2021 - This is a comprehensive guidance on the diagnosis, evaluation, and management of ascites and hepatorenal syndrome in patients with chronic liver disease from the American Association for the Study of Liver Diseases (AASLD). It replaces the prior A...

Prevalence of chronic hepatitis B phases in Eritrean patients: a laboratory-based cross...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088660
BMC Gastroenterology; Hamida ME, Raja SM et. al.

May 2nd, 2021 - Understanding the natural history of chronic hepatitis B (CHB) virus infection is important for determining optimal management and predicting prognosis in patients. The aim of this study was to determine the prevalence of different phases of CHB i...

The role of nursing care in the type 2 diabetes treatment associated with chronic liver...
https://doi.org/10.1097/MEG.0000000000002150
European Journal of Gastroenterology & Hepatology; Fu BY, Wang XJ

Apr 14th, 2021 - Diabetes is the fifth leading cause of death in the People's Republic of China. The aim of the article is to compare the effects of nursing care on the laboratory findings and ultrasound results of diabetic patients with chronic liver diseases (CL...

see more →

Guidelines  9 results

Brazilian Society of Hepatology and Brazilian College of Radiology practice guidance fo...
https://doi.org/10.1016/j.aohep.2021.100341
Annals of Hepatology; Cardoso AC, A Villela-Nogueira C et. al.

Mar 19th, 2021 - In 2015 the European Association for the Study of Liver Diseases (EASL) and the Asociación Latinoamericana para el Estudio del Hígado (ALEH) published a guideline for the use of non-invasive markers of liver disease. At that time, this guideline f...

Optimization of the transition process of youth with liver disease in adulthood: A posi...
https://doi.org/10.1016/j.clinre.2019.07.018
Clinics and Research in Hepatology and Gastroenterology; Antonini TM, Girard M et. al.

Sep 30th, 2019 - Transition describes a progressive and highly coordinated process encompassing the transfer of a young patient from paediatric care to the adult-care system. Transfer of medical care for an adolescent to adult services is a complex and challenging...

Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the St...
https://www.aasld.org/sites/default/files/guideline_documents/PracticeGuidelines-PBC-November2018.pdf

Oct 31st, 2018 - This American Association for the Study of Liver Diseases (AASLD) 2018 Practice Guidance on Primary Biliary Cholangitis (PBC) is an update of the PBC guidelines published in 2009. The 2018 updated guidance on PBC includes updates on etiology and d.

Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Trea...
https://www.aasld.org/sites/default/files/PracticeGuidelines-HCV-November2018.pdf
AASLD-IDSA HCV Guidance Panel

Oct 29th, 2018 - Recognizing the importance of timely guidance regarding the rapidly evolving field of hepatitis C management, the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) developed a web-ba.

Surveillance and diagnostic algorithm for hepatocellular carcinoma proposed by the Live...
https://doi.org/10.1159/000368141
Oncology Kudo M, Matsui O et. al.

Nov 27th, 2014 - Surveillance and diagnostic algorithms for hepatocellular carcinoma (HCC) have already been described in guidelines published by the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver ...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  895 results

Trends in the Economic Burden of Chronic Liver Diseases and Cirrhosis in the United Sta...
https://doi.org/10.14309/ajg.0000000000001292
The American Journal of Gastroenterology; Ma C, Qian AS et. al.

May 17th, 2021 - The management of chronic liver diseases (CLDs) and cirrhosis is associated with substantial healthcare costs. We aimed to estimate trends in national healthcare spending for patients with CLDs or cirrhosis between 1996 and 2016 in the United Stat...

Subjective Global Nutritional Assessment as a nutritional tool in childhood chronic liv...
https://doi.org/10.1017/S0007114521001604
The British Journal of Nutrition; Pawaria A, Khanna R et. al.

May 14th, 2021 - Objective of the study was to assess subjective global nutritional assessment (SGNA) in children with chronic liver diseases (CLD). Children aged 3 months to 18 years with CLD were prospectively enrolled (January 2016 to October 2018). SGNA was pe...

Diagnosis, evaluation, and management of ascites and hepatorenal syndrome.
https://doi.org/10.1002/hep.31884
Hepatology (Baltimore, Md.); Biggins SW, Angeli P et. al.

May 4th, 2021 - This is a comprehensive guidance on the diagnosis, evaluation, and management of ascites and hepatorenal syndrome in patients with chronic liver disease from the American Association for the Study of Liver Diseases (AASLD). It replaces the prior A...

Prevalence of chronic hepatitis B phases in Eritrean patients: a laboratory-based cross...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088660
BMC Gastroenterology; Hamida ME, Raja SM et. al.

May 2nd, 2021 - Understanding the natural history of chronic hepatitis B (CHB) virus infection is important for determining optimal management and predicting prognosis in patients. The aim of this study was to determine the prevalence of different phases of CHB i...

The role of nursing care in the type 2 diabetes treatment associated with chronic liver...
https://doi.org/10.1097/MEG.0000000000002150
European Journal of Gastroenterology & Hepatology; Fu BY, Wang XJ

Apr 14th, 2021 - Diabetes is the fifth leading cause of death in the People's Republic of China. The aim of the article is to compare the effects of nursing care on the laboratory findings and ultrasound results of diabetic patients with chronic liver diseases (CL...

see more →

News  97 results

New AASLD Guidelines Ask Us to Reconsider How We View Bleeding Risk in Cirrhosis
https://www.medscape.com/viewarticle/946425

Mar 3rd, 2021 - This transcript has been edited for clarity. Hello. I'm Dr David Johnson, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School in Norfolk, Virginia. Kudos to the American Association for the Study of Liver Disease...

Risk Factors Can Help Spot People Who Need Hep D Screening
https://www.medscape.com/viewarticle/940855

Nov 12th, 2020 - NEW YORK (Reuters Health) - Several risk factors associated with hepatitis D virus (HDV) infection can be used to identify people who should be screened, researchers report. "It was interesting to find that the risk factors that were identified in...

Semaglutide Shows Promise in NASH Phase 2 Study
https://www.medscape.com/viewarticle/940975

Nov 12th, 2020 - Almost 60% of patients with biopsy-confirmed nonalcoholic steatohepatitis and liver fibrosis showed resolution of NASH after treatment with semaglutide,according to a phase 2, double-blind, randomized, placebo-controlled trial published in the New...

Treating Liver Disease During COVID-19: New Recommendations
https://www.staging.medscape.com/viewarticle/930411

May 13th, 2020 - Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The COVID-19 pandemic presents myriad challenges to hepatologists, gastroenterologists, transplant programs, primary care providers, and, of course, their patien...

Fast Five Quiz: Nonalcoholic Steatohepatitis (NASH)
https://reference.staging.medscape.com/viewarticle/929475_6

May 10th, 2020 - Weight loss is a recommended treatment strategy for NASH. The American Association for the Study of Liver Diseases (AASLD) indicate that a 3%-5% weight loss reduces hepatic steatosis, but that up to a 10% weight loss might be needed to improve nec...

see more →

Patient Education  2 results see all →